global harmonization of medical device regulation: accomplishments, challenges and opportunities
DESCRIPTION
Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities. Larry Kessler, Sc.D. Director Office of Science and Engineering Laboratories CDRH, FDA Chair, Global Harmonization Task Force. Accomplishments to Date. Forum for open discussion - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/1.jpg)
Global Harmonization of Medical Device Regulation:
Accomplishments, Challenges and Opportunities
• Larry Kessler, Sc.D.• Director• Office of Science and
Engineering Laboratories• CDRH, FDA• Chair, Global Harmonization
Task Force
![Page 2: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/2.jpg)
Accomplishments to Date
• Forum for open discussion• Development of
harmonized guidance• Interaction with other
organizations• Education for nations with
emerging systems• Emerging technologies and
related issues
![Page 3: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/3.jpg)
GHTF Challenges
• Differing regulatory paradigms
• Maturity of systems varies
• Significant cultural differences
• Incorporating non-binding “guidance” into legislation and/or regulation difficult for FDA in short time period
• When to emphasize emerging issues
![Page 4: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/4.jpg)
Specific Challenges
• Premarket authorization– Essential principles conformance vs. review
• Postmarket surveillance– Mature system in the US many reports vs.
“case study” approach
• Quality Systems– Incorporating risk management
• Auditing– Format– Depth of Audit
![Page 5: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/5.jpg)
Let’s Talk Turkey: Obstacles
• Regulatory organizations must harmonize– Agencies have not moved their process– Public declaration vs. de facto practice
• Industry must get engaged– Summary Technical Evaluation Document not
used often: highest or lowest denominator?– Few volunteers for joint inspections: concern
about impact of one bad inspection?
![Page 6: Global Harmonization of Medical Device Regulation: Accomplishments, Challenges and Opportunities](https://reader030.vdocuments.us/reader030/viewer/2022032612/56812f9c550346895d95176b/html5/thumbnails/6.jpg)
Taking the Task Force Forward
• Guidance Implementation– Audits– NCAR
• Organizational Logistics– Web redesign– More languages
• Expansion– Organizational– Training and dialogue